Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences operating margin
Operating margin is operating income as a percentage of revenue.
Assembly Biosciences's operating margin for the twelve months ending Jun 30, 2026 was -11.8%. For fiscal 2025 it was -16.8%, against -159.3% the year before. The highest annual figure on record is -16.8% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -16.8% | +142.5 |
| FY2024 | Dec 31, 2024 | -159.3% | +743.2 |
| FY2023 | Dec 31, 2023 | -902.5% | +1219.2 |
| FY2021 | Dec 31, 2021 | -2121.7% | −2039.8 |
| FY2020 | Dec 31, 2020 | -81.9% | +561.6 |
| FY2019 | Dec 31, 2019 | -643.4% | −17.0 |
| FY2018 | Dec 31, 2018 | -626.4% | −47.3 |
| FY2017 | Dec 31, 2017 | -579.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -47.4% | +67.8 |
| Q1 FY2026 | Mar 31, 2026 | -138.4% | −32.9 |
| Q4 FY2025 | Dec 31, 2025 | 46.6% | +203.4 |
| Q3 FY2025 | Sep 30, 2025 | -100.9% | +59.2 |
| Q2 FY2025 | Jun 30, 2025 | -115.2% | +27.8 |
| Q1 FY2025 | Mar 31, 2025 | -105.5% | +79.9 |
| Q4 FY2024 | Dec 31, 2024 | -156.7% | +18.5 |
| Q3 FY2024 | Sep 30, 2024 | -160.1% | +141.7 |
| Q2 FY2024 | Jun 30, 2024 | -143.0% | +3679.7 |
| Q1 FY2024 | Mar 31, 2024 | -185.5% | −173.9 |
| Q4 FY2023 | Dec 31, 2023 | -175.2% | −191.9 |
| Q3 FY2021 | Sep 30, 2021 | -301.8% | +376.8 |
| Q4 FY2020 | Dec 31, 2020 | -3822.8% | −3221.0 |
| Q3 FY2020 | Sep 30, 2020 | -11.6% | +602.7 |
| Q2 FY2020 | Jun 30, 2020 | 16.7% | +656.3 |
| Q1 FY2020 | Mar 31, 2020 | -678.6% | +50.8 |
| Q4 FY2019 | Dec 31, 2019 | -601.7% | +103.0 |
| Q3 FY2019 | Sep 30, 2019 | -614.3% | −87.6 |
| Q2 FY2019 | Jun 30, 2019 | -639.6% | +204.6 |
| Q1 FY2019 | Mar 31, 2019 | -729.4% | −261.7 |
| Q4 FY2018 | Dec 31, 2018 | -704.7% | −334.3 |
| Q3 FY2018 | Sep 30, 2018 | -526.7% | −58.7 |
| Q2 FY2018 | Jun 30, 2018 | -844.2% | −269.1 |
| Q1 FY2018 | Mar 31, 2018 | -467.7% | +1568.9 |
| Q4 FY2017 | Dec 31, 2017 | -370.4% | – |
| Q3 FY2017 | Sep 30, 2017 | -468.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -575.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -2036.5% | – |
See a number that looks wrong?